News-Medical.Net Gene Therapy News
-
PerkinElmer unveils industry-first cell analysis solution to streamline cell and gene therapy research and manufacturing
Sep 29, 2022 | 17:11 pmPerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.
Read more... -
Astrea Bioseparations introduces Nereus LentiHERO, a fit-for-purpose solution for lentiviral vector purification
Sep 29, 2022 | 17:03 pmAstrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology.
Read more... -
Researchers to use $1 million grant for improving blood cancer diagnosis and treatment
Sep 28, 2022 | 07:07 amAdelaide researchers will use a $1 million grant to improve the diagnosis and treatment of blood cancers, which kill 16 Australians every day.
Read more... -
Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases
Sep 23, 2022 | 20:44 pmIn a new paper, University of California, Irvine researchers explain how precision genome editing agents have enabled precise gene correction and disease rescue in inherited retinal diseases (IRDs).
Read more... -
Scientists create new tool to identify genomic safe harbor sites in specific tissues
Sep 23, 2022 | 04:16 amScientists at St. Jude Children's Research Hospital have created a tool that can find safe places to introduce genes into human DNA.
Read more... -
Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue
Sep 23, 2022 | 01:43 amMonon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
Read more... -
New imaging approach could help accelerate the development of new treatments for eye diseases
Sep 22, 2022 | 17:38 pmResearchers have developed a simple and fast way to perform optoretinography, an imaging technique that measures light-induced functional activity in the eye's retina, the network of neurons in the back of our eyes responsible for detecting light and initiating vision.
Read more... -
New board members bring significant leadership experience in the biotech sector
Sep 22, 2022 | 10:57 amAspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.
Read more... -
New genetically-targeted MND therapy could be a turning point for patient care
Sep 22, 2022 | 03:17 amScientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of a Phase 3 clinical trial showed significant physical benefits for patients after 12 months.
Read more... -
Study identifies a promising target for polycystic kidney disease treatment
Sep 17, 2022 | 01:51 amBlocking the inhibition of PKD1 and PKD2 gene expression by deleting a binding site for microRNAs hindered the formation and growth of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD) models, UT Southwestern researchers reported.
Read more...